Role of Probiotics in Depression: Connecting Dots of Gut-Brain-Axis Through Hypothalamic-Pituitary Adrenal Axis and Tryptophan/Kynurenic Pathway involving Indoleamine-2,3-dioxygenase
Authors:
Top Cited Papers
- 28 January 2025
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (6) , 7230-7241
Abstract
Depression is one of the most disabling mental disorders worldwide and characterized by symptoms including worthlessness, anhedonia, sleep, and appetite disturbances. Recently, studies have suggested that tryptophan (Trp) metabolism plays a key role in depressed mood through serotonin and kynurenine pathway involving enzyme tryptophan 5-monooxygenase (TPH) and indoleamine-2,3-dioxygenase (IDO) respectively. Moreover, during neuroinflammation, IDO is activated by proinflammatory cytokines and affects neurogenesis, cognition, disturbed hypothalamic-pituitary-adrenal (HPA) axis, and gut homeostasis by altering the gut bacteria and its metabolites like Trp derivatives. Furthermore, over the decades, researchers have focused on understanding communication between the human microbiome, especially gut microbiota, and mental health, called gut-brain-axis (GBA), particularly through Trp metabolism. Supplementation of probiotics in depression has gained attention from researchers and clinicians. However, there is limited information about probiotics supplementation on depression involving enzyme IDO and kynurenine pathway metabolites. This review discussed the potential role of probiotics in depression through the tryptophan/kynurenine pathway.Keywords
This publication has 116 references indexed in Scilit:
- The Kynurenine Pathway in Gut Permeability and InflammationInflammation, 2024
- Serum indoleamine 2, 3-dioxygenase and tryptophan-2, 3-dioxygenase: potential biomarkers for the diagnosis of major depressive disorderPsychopharmacology, 2024
- Exploring the serotonin‐probiotics‐gut health axis: A review of current evidence and potential mechanismsFood Science & Nutrition, 2023
- Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviourMetabolic Brain Disease, 2023
- PCSK9 Inhibition Reduces Depressive like Behavior in CUMS-Exposed Rats: Highlights on HMGB1/RAGE/TLR4 Pathway, NLRP3 Inflammasome Complex and IDO-1Journal of Neuroimmune Pharmacology, 2023
- The Role of Early Life Stress in HPA Axis and Anxiety2020
- The role of inflammation and the gut microbiome in depression and anxietyJournal of Neuroscience Research, 2019
- The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide preventionEuropean Archives of Psychiatry and Clinical Neuroscience, 2010
- Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortexPsychopharmacology, 2002
- Quinolinic Acid and Active Oxygens1996